SAFETY, IMMUNE RESPONSE AND PRELIMINARY EFFICACY OF PPV-06 ACTIVE IMMUNOTHERAPY, A VACCINE FOR INFLAMMATORY KNEE OSTEOARTHRITIS: A PHASE 1, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, DOSE ESCALATION STUDY

Authors
Category Primary study
ConferenceOsteoarthritis and Cartilage
Year 2024
This article has no abstract
Epistemonikos ID: cb93fee628be9a3a5751bd300463a6e4d20175e1
First added on: Apr 29, 2026